Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.

Abstract

BACKGROUND:

Although artificial ulcers generally heal faster than Helicobacter pylori-related or nonsteroidal anti-inflammatory drug-related peptic ulcers, endoscopic submucosal dissection (ESD)-induced gastric ulcers are usually treated with a proton pump inhibitor (PPI) for 4-8 weeks. The effect of oral administration of a PPI for 1 week on ESD-induced gastric ulcers has not yet been evaluated. In the present study, we evaluated the efficacy of oral PPI for 1 week in patients with ESD-induced ulcers.

METHODS:

We selected 45 patients who underwent ESD for gastric mucosal tumors between June 2005 and July 2006 at Toyama University Hospital, and who met our inclusion criteria. All patients received omeprazole intravenously for 2 days after ESD and then orally for 1 week to prevent bleeding. Twenty two patients received no further omeprazole therapy (1-week group) and the rest received omeprazole orally for 7 more weeks (8-week group). Follow-up endoscopy was performed at 1 day, 4 weeks, and 8 weeks after ESD. We compared the ulcer healing rates between both groups.

RESULTS:

There were no significant differences between the groups in the ulcer-healing rate, because ulcers healed in 22 (96%) and 20 (91%) patients from the 8-week and 1-week groups, respectively.

CONCLUSIONS:

In our study, oral administration of omeprazole for 1 week was sufficient to achieve healing of ESD-induced artificial gastric ulcers. A larger prospective trial will be required to confirm these findings.

• Authors: Shinya Kajiura, Ayumu Hosokawa, Akira Ueda, Hiroshi Mihara, Takayuki Ando, Haruka Fujinami, Jun Nishikawa, Kohei Ogawa, Masami Minemura, Toshiro Sugiyama
• Journal: BMC research notes (BMC Res Notes) Vol. 8 Pg. 150 (Apr 15 2015) ISSN: 1756-0500 [Electronic] England
• PMID: 25889379 (Publication Type: Journal Article)

Chemical References

• Anti-Ulcer Agents
• Proton Pump Inhibitors
• Omeprazole

Topics

• Adenocarcinoma (diagnosis, pathology, surgery)
• Adenoma (diagnosis, pathology, surgery)
• Aged
• Anti-Ulcer Agents (therapeutic use)
• Female
• Gastric Mucosa (pathology, surgery)
• Gastroscopy (adverse effects)
• Humans
• Male
• Middle Aged
• Omeprazole (therapeutic use)
• Proton Pump Inhibitors (therapeutic use)
• Retrospective Studies
• Stomach Neoplasms (diagnosis, pathology, surgery)
• Stomach Ulcer (drug therapy, etiology, pathology)
• Time Factors
• Treatment Outcome
• Wound Healing (drug effects)